Phase III Comm. 3 Lunch Break Lunch Break Lunch Break Lunch Break Lunch Break Lunch Break

Similar documents
Electrocardiography Gönenç Kocabay Electrocardiography Gönenç Kocabay Electrocardiography Gönenç Kocabay

CODE DISCIPLINE THEORETICAL PRACTICAL TOTAL 1-ANESTHESIOLOGY AND REANIMATION

Cardiovascular and Pulmonary System

Cardiovascular and Pulmonary System

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Cardiovascular 1. Wednesday August 15. C10 Cardiac contractility. C64 Cardiac hemodynamics IL. C16 Heart valve disease IL

Group B: Directed self-study Group C: Anatomy lab. Lecture: Structure and function of larynx. Lecture: Dead space & compliance of lungs

Block 4 VIRGINIA CAMPUS Cardiovascular and Pulmonary Systems 2018

ARRHYTHMIAS AND DEVICE THERAPY

OST 580 Respiratory Spring Semester OST 580 Respiratory Medicine Course Schedule

Pulmonary Pathophysiology

CuRe PreClerkship Presentation. CARDIOVASCULAR COURSE Anita Soni MD FRCP (C) January 23, 2014

VM 747 CLINICAL SCIENCES II. Cardiology and Respiratory Medicine. Spring 2013

Index. Note: Page numbers of article titles are in boldface type.

WF RESPIRATORY SYSTEM. RESPIRATORY MEDICINE

INSTITUTE FOR PULMONARY DISEASES SREMSKA KAMENICA

A DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12

GOALS AND INSTRUCTIONAL OBJECTIVES

Mayo Clinic Physician Assistant Board Review

Exercise Test: Practice and Interpretation. Jidong Sung Division of Cardiology Samsung Medical Center Sungkyunkwan University School of Medicine

The subject is composed from theoretical lectures and clinical practicals.

OPJS UNIVERSITY,CHURU(RAJASTHAN) SYLLABUS FOR DIPLOMA IN CARDIAC PERFUSION TECHNOLOGY (DCPT)

Cardiology. Objectives. Chapter

Student Outline. Improving Transportation Safety: Commercial Driver Medical Examiner Training CHAPTER 1. General FMCSA Information

Specific Basic Standards for Osteopathic Fellowship Training in Pulmonary / Critical Care Medicine

Physical and Functional Diagnosis in Cardiovascular and pulmonary sciences

Blood and Circulation Module Year 3 Semester 1

LAC-USC Cardiology Consult Service

CCR Keywords Primary keywords

Anatomy. The respiratory system starts from the nose, mouth, larynx, trachea, and the two lungs.

Respiratory Diseases and Disorders

Physiotherapy in Cardiovascular and pulmonary Sciences

PROPAEDEUTICS OF INTERNAL DISEASES EXAMINATION SYLLABUS. Part I - General

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

Summary of Research and Writing Activities In Cardiovascular Disease

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

Core Safety Profile. Pharmaceutical form(s)/strength: Film-coated tablets 1.25 mg, 2.5 mg, 3.75 mg, 5 mg, 7.5 mg and 10 mg. Date of FAR:

Shortness of Breath. Abdulrahman Al Frayh. Professor of Pediatrics Consultant Pediatric Pulmonologist King Saud University

Severe Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes

General Principles: 5% 7%

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives

ACC 2015 Core Cardiovascular Training Statement (COCATS 4) Competency Tables

NurseAchieve. CHAPTERS INCLUDED IN THE NURSEACHIEVE COMPREHENSIVE NCLEX REVIEW NURSING SKILLS AND FUNDAMENTALS:

MEDICAL FACULTY DEPARTMENT OF PATHOPHYSIOLOGY QUESTION FOR ORAL PART OF EXAM MEDICAL STUDENTS

The following list provides the learning objectives that will be covered in the lectures, and tutorials of each week:

HEART FAILURE. Study day November 2017 Sarah Briggs and Janet Laing

SPECIAL PATHOPHYSIOLOGY SHOCK

Preliminary Programme

Cardiology/Cardiothoracic

Lnformation Coverage Guidance

Cardiac Stress Testing What Stress is Best?

USMLE STEP 2 CK REVIEW STUDY GUIDE

Coronary Heart Disease. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N

Common Codes for ICD-10

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

APR-DRG Description Ave Charge

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

CARDIOLOGY SELECTIVE. Administrator: Lupe Romero-Villanueva Phone: Office: 750 Welch Road, Suite 305

Contra-indications, Risks, and Safety Precautions for Stress Testing. ACSM guidelines, pg 20 7 ACSM RISK FACTORS. Risk Classifications pg 27

Lahey Clinic Internal Medicine Residency Program: Curriculum for Cardiovascular Medicine Rotation

ETMC-EMS PARAMEDIC COURSESCHEDULE Oct 25, 2017 to Aug 16, 2018 Varied Day Shift Class DSHS Course #

Acute Myocardial Infarction

Exam 2 Respiratory Disorders

Drug prescriptions (Pharm) Exposure (36/48 months)

Proper Completion of a Death Certificate"

Appendix 1: Supplementary tables [posted as supplied by author]

Respiratory Disease. Dr Amal Damrah consultant Neonatologist and Paediatrician

Virginia Western Community College DNH 120 Management of Emergencies

UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE. Plan of the course. Basics of Pediatric Allergy. Academic year 2015/2016. Mirjana Turkalj

The Respiratory System

COPD as a comorbidity of heart failure in elderly patients

KING SAUD UNIVERSITY COLLEGE OF MEDICINE WEEK 1 RESPIRATORY BLOCK (Female) CHAIR PERSON: Dr. Malak El-Hazmi

Respiratory system. Applied Anatomy &Physiology

Chapter 13. Respiratory Emergencies

DNH 120 Management of Emergencies

Index. Note: Page numbers of article titles are in boldface type.

ACOFP 55th Annual Convention & Scientific Seminars. How Complicated is Your Panel? Effective Risk Coding in Primary Care. Alison Mancuso, DO, FACOFP

Ischaemic heart disease. IInd Chair and Clinic of Cardiology

Instruct patient and caregivers: Need for constant monitoring Potential complications of drug therapy

CALGARY ZONE PULMONARY REFERRAL QUICK REFERENCE

Appropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating)

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Chapter 10 Respiratory System J00-J99. Presented by: Jesicca Andrews

Pulmonary Pearls. Medical Pearls. Case 1: Case 1 (cont.): Case 1: What is the Most Likely Diagnosis? Case 1 (cont.):

GRAZ TUTORIAL. Education in partnership. October 15 19, 2018 Graz/Austria. myesr.org/esor

Rotation: Imaging 2. Nuclear Cardiology (in Imaging 1 and 2)

Course Title Systematic Pharmacology I

Cardiothoracic and Cardiothoracic Surgery ICD-10-CM 2014: Reference Mapping Card

SPECIAL PATHOPHYSIOLOGY CARDIO-VASCULAR SYSTEM

TTC Catalog - Respiratory Care (RES)

Chronic Obstructive Pulmonary Disease

Respiratory Module Study Guide A Course Title Respiratory Module B

Adult Congenital Heart Disease Certification Examination Blueprint

Course Schedule: Pharmacotherapy II Spring 2011 Revised 12/6/2010

Index. Note: Page numbers of article titles are in boldface type.

When Should I Order a Stress Test or an Echocardiogram

Pharmacologic Therapy of Coronary Disease

Anesthesia for Cardiac Patients for Non Cardiac Surgery. Kimberly Westra DNP, MSN, CRNA

Function of the Respiratory System. Exchange CO2 (on expiration) for O2 (on inspiration)

Transcription:

Phase III Comm. 3 13-Nov-17 09.00-09.50 Study Hours Monday 10.00-10.50 Study Hours 11.00-11.50 Introduction to Autonomous Nervous system Pharmacology A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 12.00-12.50 Introduction to Autonomous Nervous system Pharmacology A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 14.00-14.50 History taking, symptoms and definitions in cardiovascular system S. YILMAZER CARDIOLOGY 15.00-15.50 History taking, symptoms and definitions in cardiovascular system S. YILMAZER CARDIOLOGY 14-Nov-17 09.00-09.50 Signs and symptoms in respiratory diseases N. SARIMAN CHEST DISEASES Tuesday 10.00-10.50 Signs and symptoms in respiratory diseases N. SARIMAN CHEST DISEASES 11.00-11.50 Physical examination in cardiovascular system S. YILMAZER CARDIOLOGY 12.00-12.50 Signs and symptoms of heart disease- Chest Pain-Cyanosis N. E. DURAN CARDIOLOGY 15-Nov-17 09.00-09.50 Study Hours Wednesday 10.00-10.50 Atherosclerosis and hypertension A. HAHOLU PATHOLOGY 11.00-11.50 Vasculitis A. HAHOLU PATHOLOGY 12.00-12.50 Agents acting at the neuromuscular junction and autonomic ganglia A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 14.00-14.50 Auscultation of heart sounds and murmurs N. E. DURAN CARDIOLOGY 15.00-15.50 Signs and symptoms of heart disease- Dyspnea and Oedema S. YILMAZER CARDIOLOGY 16-Nov-17 09.00-09.50 Electrocardiography uses and practice N. E. DURAN CARDIOLOGY Thursday 10.00-10.50 Arterial blood gases N. SARIMAN CHEST DISEASES 11.00-11.50 Lung function tests N. SARIMAN CHEST DISEASES 12.00-12.50 Lung function tests N. SARIMAN CHEST DISEASES 14.00-14.50 Electrocardiography S. YILMAZER CARDIOLOGY 15.00-15.50 Electrocardiography S. YILMAZER CARDIOLOGY 17-Nov-17 09.00-09.50 Congenital cardiac diseases A. HAHOLU PATHOLOGY Friday 10.00-10.50 Congenital cardiac diseases A. HAHOLU PATHOLOGY 11.00-11.50 Parasympathomimetic agents A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 14.00-14.50 Parasympathomimetic agents A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 15.00-15.50 Parasympatholytic agents A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 20-Nov-17 09.00-09.50 Obstructive lung diseases (COPD, Bronchial Asthma, Bronchiectasis) N. SARIMAN CHEST DISEASES Monday 10.00-10.50 Obstructive lung diseases (COPD, Bronchial Asthma, Bronchiectasis) N. SARIMAN CHEST DISEASES 11.00-11.50 Sympathomimetic agents A. Ç. ÖĞÜTMAN M. PHARMACOLOGY

12.00-12.50 Sympathomimetic agents A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 14.00-14.50 Ischemic heart diseases A. HAHOLU PATHOLOGY 21-Nov-17 09.00-09.50 Study Hours Tuesday 10.00-10.50 Problem based learning-session I N. SARIMAN PBL 11.00-11.50 Pneumonia N. SARIMAN CHEST DISEASES 12.00-12.50 Pneumonia N. SARIMAN CHEST DISEASES 15 00-15 50 ENG 315 - English for Medicine V ENGLISH 22-Nov-17 09.00-09.50 Tuberculosis N. SARIMAN CHEST DISEASES Wednesday 10.00-10.50 Tuberculosis N. SARIMAN CHEST DISEASES 11.00-11.50 Sympatholytic agents A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 12.00-12.50 Drugs used for ischemic heart diseases A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 14.00-14.50 Hypertension, clinics and laboratory findings N. E. DURAN CARDIOLOGY 15.00-15.50 Nasal and sinus diseases Ö. ÇELİK ENT 16.00-16.50 Diseases of pharynx and larynx Ö. ÇELİK ENT 23-Nov-17 09.00-09.50 Anticoagulant, fibrinolytic and antiplatelet drugs A. Ç. ÖĞÜTMAN M. PHARMACOLOGY Thursday 10.00-10.50 Anticoagulant, fibrinolytic and antiplatelet drugs A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 11.00-11.50 Pleural effusion and empyema N. SARIMAN CHEST DISEASES 12.00-12.50 Pleural effusion and empyema N. SARIMAN CHEST DISEASES 14.00-14.50 Measuring blood pressure and examination of the extremities N. E. DURAN CARDIOLOGY 15.00-15.50 Electrocardiography S. YILMAZER CARDIOLOGY 16.00-16.50 Electrocardiography S. YILMAZER CARDIOLOGY 24-Nov-17 09.00-09.50 Respiratory System Symptoms in Children A. KUT PEDIATRIC HEALTH Friday 10.00-10.50 Respiratory System Physical Examination in Children A. KUT PEDIATRIC HEALTH 11.00-11.50 Approach to Allergic Diseases in Childhood A. KUT PEDIATRIC HEALTH 14.00-14.50 Lung tumor N. SARIMAN CHEST DISEASES 15.00-15.50 Lung tumor N. SARIMAN CHEST DISEASES 27-Nov-17 09.00-09.50 Occupational lung diseases N. SARIMAN CHEST DISEASES Monday 10.00-10.50 Occupational lung diseases N. SARIMAN CHEST DISEASES 11.00-11.50 Tachyarrhythmias (supraventricular and ventricular arrytmias) S. YILMAZER CARDIOLOGY 12.00-12.50 Tachyarrhythmias (supraventricular and ventricular arrytmias) S. YILMAZER CARDIOLOGY 14.00-14.50 Diuretic drugs A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 15.00-15.50 Diuretic drugs A. Ç. ÖĞÜTMAN M. PHARMACOLOGY

16.00-16.50 Problem based learning-session II N. SARIMAN PBL 28-Nov-17 09.00-09.50 Anticoagulant, fibrinolytic and antiplateledrugs A. Ç. ÖĞÜTMAN M. PHARMACOLOGY Tuesday 10.00-10.50 Renin-angiotensin system pharmacology A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 11.00-11.50 Anti-arrhytmic drugs Z. G. ÖZÜNAL M. PHARMACOLOGY 12.00-12.50 Anti-arrhytmic drugs Z. G. ÖZÜNAL M. PHARMACOLOGY 29-Nov-17 09.00-09.50 Cardiomyopathies A. HAHOLU PATHOLOGY Wednesday 10.00-10.50 Antihypertensive agents A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 11.00-11.50 Antihypertensive agents A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 12.00-12.50 Pharmacotherapy of heart failure A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 14.00-14.50 Interstitial lung diseases N. SARIMAN CHEST DISEASES 15.00-15.50 Sarcoidosis N. SARIMAN CHEST DISEASES 30-Nov-17 09.00-09.50 Beta adrenerjic reseptor blockers A. Ç. ÖĞÜTMAN M. PHARMACOLOGY Thursday 10.00-10.50 Drugs therapy for hypercholesterolemia and dyslipidemia Z. G. ÖZÜNAL M. PHARMACOLOGY 11.00-11.50 Drugs therapy for hypercholesterolemia and dyslipidemia Z. G. ÖZÜNAL M. PHARMACOLOGY 12.00-12.50 Atherosclerosis and Coronary artery disease definition and S. YILMAZER CARDIOLOGY 14.00-14.50 Heart Failure A. HAHOLU PATHOLOGY 15.00-15.50 Heart Failure A. HAHOLU PATHOLOGY 16.00-16.50 Simulated patient meeting-information N. SARIMAN SIMULATION 1-Dec-17 09.00-09.50 Upper respiratory diseases A. HAHOLU PATHOLOGY Friday 10.00-10.50 Upper respiratory diseases A. HAHOLU PATHOLOGY 11.00-11.50 Heart failure definition pathophysiology management N. E. DURAN CARDIOLOGY 14.00-14.50 Pharmacotherapy for obstructive pulmonary diseases A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 15.00-15.50 Pharmacotherapy for obstructive pulmonary diseases A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 4-Dec-17 09.00-09.50 Obstructive Diseases A. HAHOLU PATHOLOGY Monday 10.00-10.50 Congenital anomalies, atelectasis A. HAHOLU PATHOLOGY 11.00-11.50 Drugs used for peripheral vascular diseases A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 12.00-12.50 Antitussives, mucolytics and expectorants A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 14.00-14.50 Stable angina pectoris Clinical manifestation and definition N. E. DURAN CARDIOLOGY 15.00-15.50 Unstable Angina Pectoris and myocardial infarction S. YILMAZER CARDIOLOGY 16.00-16.50 Unstable Angina Pectoris and myocardial infarction S. YILMAZER CARDIOLOGY 5-Dec-17 09.00-09.50 Hemostatic and replacement drugs Z. G. ÖZÜNAL M. PHARMACOLOGY Tuesday 10.00-10.50 Physical examination of the thorax N. SARIMAN CHEST DISEASES 11.00-11.50 Physical examination of the thorax N. SARIMAN CHEST DISEASES

12.00-12.50 Restrictive Diseases A. HAHOLU PATHOLOGY 6-Dec-17 09.00-09.50 Pulmonary Ventilation Perfusion Scintigraphy T. Y. ERDİL NUCLEAR MEDICINE Wednesday 10.00-10.50 Pulmonary Embolism and Use of PET in Lungs T. Y. ERDİL NUCLEAR MEDICINE 11.00-11.50 Nuclear Medicine applications in cardiovascular diseases T. Y. ERDİL NUCLEAR MEDICINE 12.00-12.50 Nuclear Medicine applications in cardiovascular diseases T. Y. ERDİL NUCLEAR MEDICINE 14.00-14.50 Drugs used in fluid electrolyte imbalances A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 15.00-15.50 Drugs used in Acid base balance disorders A. Ç. ÖĞÜTMAN M. PHARMACOLOGY 7-Dec-17 09.00-09.50 Granulomatous Diseases A. HAHOLU PATHOLOGY Thursday 10.00-10.50 Granulomatous Diseases A. HAHOLU PATHOLOGY 11.00-11.50 Circulatory and Respiratory Systems Radiology G. ARSLAN RADIOLOGY 12.00-12.50 Approach to Syncope N. E. DURAN CARDIOLOGY 14.00-14.50 Anaphylaxis A. KUT PEDIATRIC HEALTH 15.00-15.50 Asthma in Childhood A. KUT PEDIATRIC HEALTH 8-Dec-17 09.00-09.50 Allergic Rhinitis in Childhood A. KUT PEDIATRIC HEALTH Friday 10.00-10.50 Atopic Dermatitis in Childhood A. KUT PEDIATRIC HEALTH 11.00-11.50 Atopic Dermatitis in Childhood A. KUT PEDIATRIC HEALTH 14.00-14.50 Simulated patient meeting-feedbacs-recording videos N. SARIMAN SIMULATION 15.00-15.50 Cardiopulmonary Arrest and Resusitation O. SELVİ ANESTHESIOLOGY 11-Dec-17 09.00-09.50 Pulmonary neoplasms, pleural and mediastinal diseases A. HAHOLU PATHOLOGY Monday 10.00-10.50 Pulmonary neoplasms, pleural and mediastinal diseases A. HAHOLU PATHOLOGY 11.00-11.50 Physical examination of the thorax (Medical skills lab) N. SARIMAN CHEST DISEASES 12.00-12.50 Physical examination of the thorax (Medical skills lab) N. SARIMAN CHEST DISEASES 12-Dec-17 09.00-09.50 Plasma expanding solutions Z. G. ÖZÜNAL M. PHARMACOLOGY Tuesday 10.00-10.50 PATHOLOGY: Macroscopic and microscopic changes in Heart and Blood P-LAB LABORATORY 11.00-11.50 PATHOLOGY: Macroscopic and microscopic changes in lung and pleural P-LAB LABORATORY 12.00-12.50 Problem based learning-session III N. SARIMAN PBL

13-Dec-17 09.00-09.50 Study Hours Wednesday 10.00-10.50 Study Hours 14-Dec-17 09.00-09.50 Study Hours Thursday 10.00-10.50 Study Hours 15-Dec-17 09.00-09.50 Study Hours Friday 10.00-10.50 Study Hours 18-Dec-17 09.00-09.50 Study Hours Monday 10.00-10.50 Study Hours 19-Dec-17 09.00-09.50 Study Hours Tuesday 10.00-10.50 Study Hours 20-Dec-17 09.00-09.50 Study Hours Wednesday 10.00-10.50 Study Hours

21-Dec-17 09.00-09.50 Study Hours Thursday 10.00-10.50 Study Hours 22-Dec-17 09.00-09.50 Study Hours Friday 10.00-10.50 Study Hours 13.00-13.50 PRACTICAL PATHOLOGY and THEORETICAL EXAM EXAM 14.00-14.50 PRACTICAL PATHOLOGY and THEORETICAL EXAM EXAM 15.00-15.50 PRACTICAL PATHOLOGY and THEORETICAL EXAM EXAM